Clinical Trials Browser

Phase 1/2 × INDUSTRY × SCLC,Extensive Stage × Clear all

NCT05505825 2025-03-12

A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

Phase 1/2 Completed

SCLC,Extensive Stage